EUVIMEDEUVIMED entdecken
Crossref

Formulation and Evaluation of Orodispersible Tablet of Desloratadine By Applying Taste Masking Technology

Phanse V. R, Silawat N

International Journal of Drug Delivery Technology · 25.12.2025 · 15 (04)

DOI: 10.25258/ijddt.15.4.17 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.12.2025. Verfasst von Phanse V. R und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To develop and optimize taste-masked orodispersible tablets of desloratadine using ion-exchange resin complexation technology for enhanced patient compliance and therapeutic efficacy in allergic rhinitis management. Materials and methods: Drug-resin complexes were prepared using Indion 204 at various ratios and characterized by FTIR and DSC. Orodispersible tablets were formulated using 3² factorial design with Kyron T-314 (0.75-2.25 mg) and sodium starch glycolate (6-12 mg) as independent variables. Response surface methodology optimized hardness and disintegration time. Pharmacokinetic studies compared optimized formulation with marketed tablets in Wistar rats.

Results

Indion 204 achieved optimal drug loading (98.4%) at 1:4 ratio with confirmed molecular interactions. Formulation F9 was selected as optimal based on minimal hardness (1.76 Kg/cm²) and rapid disintegration (24.1 seconds) predicted by quadratic models (R² >0.86). F9 demonstrated superior dissolution (95.8% in 15 minutes), enhanced bioavailability (268.13% relative), reduced Tmax (2.17 hours), and excellent stability over six months with acceptable f₂ similarity factors (≥50).

Conclusion

The optimized formulation successfully addresses critical compliance issues through effective taste masking and rapid drug delivery, offering significant clinical advantages for pediatric and geriatric populations. This patient-friendly approach demonstrates strong potential for clinical translation and commercial development, warranting human bioequivalence studies and scale-up optimization.

Zitieren

APA

R, P. V., & N, S. (2025). Formulation and Evaluation of Orodispersible Tablet of Desloratadine By Applying Taste Masking Technology. International Journal of Drug Delivery Technology, 15(04). https://doi.org/10.25258/ijddt.15.4.17

Vancouver

R PV, N S. Formulation and Evaluation of Orodispersible Tablet of Desloratadine By Applying Taste Masking Technology. International Journal of Drug Delivery Technology. 2025;15(04). doi:10.25258/ijddt.15.4.17

BibTeX
@article{R2025,
  author = {R, Phanse V. and N, Silawat},
  title = {Formulation and Evaluation of Orodispersible Tablet of Desloratadine By Applying Taste Masking Technology},
  journal = {International Journal of Drug Delivery Technology},
  year = {2025},
  volume = {15},
  number = {04},
  doi = {10.25258/ijddt.15.4.17}
}
Kostenlos starten →